BioSpace News Archive

Business

CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

CytomX Therapeutics, Inc. today announced that it will report first quarter 2024 results and provide an initial CX-904 Phase 1a dose escalation update on Wednesday, May 8, 2024, after the close of U.S. markets.

May 1, 2024
·
2 min read
Business

Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

Akari Therapeutics, Plc announced leadership changes, including the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D. as interim CEO.

May 1, 2024
·
16 min read
Business

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

electroCore, Inc. today announced that it will report financial results for the first quarter ended March 31, 2024, after the close of the market on Wednesday, May 8, 2024.

May 1, 2024
·
1 min read
Business

Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update

Aadi Bioscience, Inc. today announced that it will host a conference call and live webcast on Wednesday, May 8, 2024.

May 1, 2024
·
2 min read
Pharm Country

Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024

Hoth Therapeutics, Inc. is scheduled to attend the EF Hutton Annual Global Conference in New York, NY.

May 1, 2024
·
1 min read
FDA

US FDA approves high-concentration, citrate-free formulation of Cyltezo® (adalimumab-adbm) injection, Boehringer Ingelheim’s interchangeable* biosimilar to Humira®

Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the high-concentration, citrate-free formulation of Cyltezo® (adalimumab-adbm), the company’s interchangeable* biosimilar to Humira® (adalimumab), to treat multiple chronic inflammatory diseases.

May 1, 2024
·
11 min read
Policy

Monogram Provides Regulatory Update Following Meeting with FDA

Monogram Orthopaedics Inc. today provided an update related to the regulatory and commercialization path for its mBos surgical system following its meeting with the U.S. Food and Drug Administration.

May 1, 2024
·
7 min read
Biotech Beach

Bionet America, Inc. Launches New Brio XVet Multiparameter Veterinary Monitors

Bionet America, Inc. announced the launch of the new Brio XVet series, a groundbreaking line of multiparameter monitors for use in veterinary surgery.

May 1, 2024
·
2 min read
Business

Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024

Marinus Pharmaceuticals, Inc. today announced that it plans to release financial results for the first quarter ended March 31, 2024 before market open on May 8, 2024.

May 1, 2024
·
1 min read
Alpha Tau to Participate in May 2024 Investor Conferences

Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that CFO Raphi Levy will present at the following investor conferences in May 2024.

May 1, 2024
·
1 min read